15min chapter

The HemOnc Pulse cover image

Part One: The Question of MRD in CLL Therapy

The HemOnc Pulse

CHAPTER

Exploring the Impact of MRD in CLL Therapy

This chapter delves into the significance of measurable residual disease (MRD) in chronic lymphocytic leukemia (CLL) treatment, discussing its potential influence on therapy duration, patient outcomes, and treatment selection. The speakers highlight ongoing trials investigating MRD-guided therapies, the challenges of implementing MRD-guided therapy in clinical practice, and the importance of achieving MRD negativity for patient benefit.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode